PIŚMIENNICTWO

  1. Abbasi F., Carantoni M., McLaughlin T., Reaven G. (2000): Plasma insulin concentration is more tightly linked to plasma leptin concentration than is body mass index. Metabolism, 49, 544-547.

  2. Abumrad N., Harmon C., Barnela U., Whitesell R. (1988): Insulin antagonism of catecholamine stimulation of fatty acid transport in the adipocyte. Studies on its mechanism of action. J.Biol. Chem., 263, 14678-14683.

  3. Ahiborg G., Felig P. (1982): Lactate and glucose exchange across the forearm, legs, and splanchnic bed during and after prolonged exercise. J.Clin. Invest., 69, 45-54.

  4. Ahima R., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., Flier J. (1996): Role of leptin in the neuroendocrine response to fasting. Nature, 382, 250-252.

  5. Alpert M., Hashimi M. (1993): Obesity and the heart. Am.J.Med.Sci., 306, 117-123.

  6. Al-Shoumer K., Anyaoku V., Richmond W., Johnston D. (1997): Elevated leptin concentrations in growth hormone- deficient hypopituitary adults. Clin.Endocrinol., 47, 153-159.

  7. Amador M., Ramos L., Morono M., Hermelo M. (1990): Growth rate reduction during energy restriction in obese adolescents. Exp.Clin.Endocrinol., 96(1), 73-82.

  8. Andersen P., Lund S., Schmitz O., Kahn B. (1993): Increased insulin-stimulated glucose uptake in athletes: the importance of GLUT-4 mRNA.GLUT-4 protein and fibre type composition of skeletal muscle. Acta Physiol.Scand., 149, 393-404.

  9. Arch J., Stock M., Trayhurn P. (1998): Leptin resistance in obese humans: does it exist and what does it mean? Int.J.Obes.Relat.Metab.Disord., 22, 1159-1163.

  10. Arner P. (1995): Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann.Med., 27, 435-438.

  11. Assman G., Schulte H., Eckardstein A. von (1996): Hypertriglyceridemia and elevated levels of lipoprotein (a) are risk for major coronary events in middle-aged men. Am.J.Cardiol., 77, 1179-1184.

  12. (strand P.O., Rhyming I. (1954): A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J.Appl.Physiol., 9, 2-8.

  13. Babińska Z., Hebanowski M. (2001): Otyłość - światowa epidemia. Medycyna po Dyplomie, 10, 9.

  14. Babińska Z., Zdrojewski T., Babicz-Zielińska E., Łysiak-Szydłowska W., Szynkiewicz M., Pieńkowski R., Krupa-Wojciechowska B. (1998): Nadwaga i otyłość oraz świadomość własnej nadwagi u dorosłych Polaków w 1997 roku – ocena za pomocą sondażu reprezentatywnego. Czynniki Ryzyka, 4, 41-48.

  15. Bado A., Levasseur S., Attoub S., Kermorgant S., Laigneau J., Bortoluzzi M., Moizo L., Lehy T., Guerre-Millo M., Le Marchand-Brustel Y., Lewin M. (1998): The stomach is a source of leptin. Nature, 394 (6695), 790-793.

  16. Banks W., Clewer C., Farell C. (2000): Partial saturation and regional variation in the blood-to-brain transport of leptin normal weight mice. Am.J.Physiol., 278, E1158-E1165.

  17. Banks W., Kastin A., Huang W., Jaspan J., Maness L. (1996): Leptin enters the brain by a saturable system independent of insulin. Peptides, 17, 305-311.

  18. Barash I., Cheung C., Weigle D., Ren H., Kabigting E., Kuijper J., Clifton D., Steiner R. (1996): Leptin is a metabolic signal to the reproductive system. Endocrinology, 137, 3144-3147.

  19. Baron A., Wallace P., Brechtel G. (1987): In vivo regulation of non-insulin mediated and insulin mediated glucose uptake by cortisol. Diabetes, 36, 1230-1237.

  20. Bar-Ör O., Baranowski T. (1994): Physical activity, adiposity and obesity among adolescents. Pediatr.Exerc.Sci., 6, 348-360.

  21. Bar-Ör O., Foreyt J., Bouchard C., Brownell K., Dietz W., Ravussin E., Salbe A., Schwenger S., Stjeor S., Torun B. (1998): Physical activity, genetic and nutritional considerations in childhood weight management. Med.Sci.Sports Exerc., 30(1), 2-10.

  22. Białkowska M., Szostak W. (1995): Wybór metody leczenia otyłości w zależności od stopnia zagrożenia zdrowia. Pol. Tyg. Lek., supl. 1, 48-50.

  23. Białkowska M., Szostak W., Cybulska B. (1990): Otyłość. [W:] Metaboliczne choroby cywilizacyjne. Red. W. Szostak, B. Cybulska. Warszawa: CMKP, 211.

  24. Björntorp P. (1985): Obesity and the risk of cardiovascular disease. Ann.Clin.Res.,17, 3-8.

  25. Björntorp P. (1990): „Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis, 10, 493-498.

  26. Björntorp P. (1992): Abdominal obesity and the metabolic syndrome. Ann. Med., 24, 465-468.

  27. Björntorp P. (1996): The regulation of adipose tissue distribution in humans. Int.J. Obes.Relat.Metab.Disord., 20, 291-302.

  28. Blaak E., Bar-Or O., Westerterp K. (1990): Effect of VLCD on daily energy expenditure and body composition in obese boy [abstracted]. Int.J.Obes., 14 (suppl. 2), 86.

  29. Blaak E., Westerterp K., Bar-Or O., Wouters L., Saris W. (1992): Total energy expenditure and spontaneous activity in relation to training in obese boys. Am.J.Clin. Nutr., 55(4), 777-782.

  30. Blum W., Albertsson-Wikland K., Rosberg S., Ranke M. (1993): Serum levels of insulin-like growth factor I (GF-1) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J.Clin. Endocrin. Metab., 76, 1610-1616.

  31. Blumstrand E., Hassmen P., Ekbom B., Newsholme E.A. (1991): Administration of branched-chain amino acid during sustained exercise - effects on performance and on plasma concentration of some amino acids. Eur.J.Appl.Physiol.Occup.Physiol., 63, 83-88.

  32. Blundel J., Hill A. (1995): Kontrola łaknienia deksfenfluraminą w leczeniu otyłości. Pol.Tyg.Lek., supl. 1, 11-19.

  33. Bobilewicz D. (1961): Metody rozdziału frakcji lipoproteinowych. Cormay-Diagnostyka, 1:4-5.

  34. Bonadonna R., Groop L., Kraemer N., Ferrannini F., Del Pranto S., De Fronzo R. (1990): Obesity and insulin resistance in humans: a dose – response study. Metabolism, 39, 452-459.

  35. Bonanome A. (1999): Factors affecting LDL-cholesterol reduction: unsaturated fatty acid. Eur.Heart J., suppl., s24-s28.

  36. Borer K. (1994): Neurohumoral mediation of exercise-induced growth. Med.Sci.Sports Exerc., 26, 6, 741-754.

  37. Bouchard C., Despres J., Mauriege P. (1993): Genetic and nongenetic determinants on regional fat distribution. Endocrin.Rev., 14, 72-93.

  38. Bovetto S., Richard D. (1995): Lesion of central nucleus of amygdala promotes fat gain without preventing effect of exercise on energy balance. Am.J.Physiol., 269, R781-R786.

  39. Bray G. (1995): Life insurance and overweight. Obes.Res., 3, 97-99.

  40. Brindley D. (1995): Role of glucocorticoids and fatty acids in the impairment of lipids metabolism observed in the metabolic syndrome. Int.J.Obes.Relat.Metab.Disord., (Suppl.1), S69-S75.

  41. Brown L., Rosner B., Willett W., Sacks F. (1999): Cholesterol-lowering effects of dietary dietary fiber: a meta-analysis. Am.J.Clin.Nutr., 69, 30-42.

  42. Campfield L., Smith F., Guisez Y., Devos R., Burn P. (1995): Recombinant mouse ob protein: evidence for peripherial signal linking adiposity and central neural network. Science, 269, 546-549.

  43. Carantoni M., Abbasi F., Azhar S., Schaaf P., Reaven G. (1999): Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance? J.Clin.Endocrinol.Metab., 84(3), 869-872.

  44. Caro J. (1991): Insulin resistance in obese and nonobese man. J.Clin.Endocrinol.Metab., 73, 691-695.

  45. Caro J., Kolaczyński J., Nyce M., Ohannesian J., Opentatowa I., Goldman W., Lynn R., Zhang P., Sinha M., Considine R. (1996): Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet, 348, 159-161.

  46. Cartec G., Holloszy J. (1990): Exercise increases susceptibility of muscle glucose transport to activation by various stimuli. Am. J. Physiol., 258, E390-E393.

  47. Castelli W. (1992): Epidemiology of triglicerides: a view from Framingham. Am. J.Cardiol., 70 (suppl.), 3H-9H.

  48. Challis R., Lozeman F., Leighton B., Newsholm B. (1986): Effects of the β-adrenoreceptor agonist isoprenaline on insulin sensitivity in soleus muscle of the rat. Biochem. J., 233, 377-381.

  49. Chen H., Charlat O., Tartaglia L.A., Woolf E., Weng X., Ellis S., Lakey N., Culpepper J., Moore K., Breitbart R., Duyk G., Tapper R., Morgernstern J. (1996): Evidence that the diabetic gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell, 84, 491-495.

  50. Chen M., Song Y., Lin P. (2000): Zinc may be a mediator of leptin production in humans. Life Sci., 66, 2143-2149.

  51. Chua S., Chung W., Wu-Peng X., Zhang Y., Liu S., Tartaglia L., Leibel R. (1996): Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science, 271, 994-996.

  52. Cinti S., Frederich R., Zigaretti M., DeMatteis R., Flier J., Lowell B. (1997): Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology, 138(2), 797-804.

  53. Coderre L., Kandron K., Vallega G., Pilch C. (1995): Identification and characterization of an exercise-sensitive pool of glucose transporters in skeletal muscle. J.Biol.Chem., 270, 27584-27588.

  54. Cohen B., Novick D., Rubinstein M. (1996): Modulation of insulin activities by leptin. Science, 274, 1185-1188.

  55. Colditz G., Willet W., Stampfer M., London S., Segal M., Speizer E. (1990): Patterns of weight change and their relation to diet in a cohort of healthy women. Am.J. Clin.Nutr., 51, 1100-1105.

  56. Connor W. (1999): Alfa-linolemic acid in health and disease. Am.J.Clin.Nutr., 69, 827-828.

  57. Constable S., Favier R., Cartec G., Young D. (1988): Muscle glucose transport: interaction of in vitro concentrations, insulin and exercise. J.Appl.Physiol., 64, 2329-2332.

  58. Cooling J., Barth J., Blundell J. (1998): The high-fat fenotype: is leptin involved in the adaptive responses to a high fat (high energy) diet? Int.J.Obes. Relat.Metab.Disord., 22, 1132-1135.

  59. Coronary Heart Disease. Reducing the risk. The scientific background for primary and secondary prevention of coronary heart disease. (1998): Nutr.Metab.Cardiovasc.Dis., 8, 205-271.

  60. Cortright R., Dohm G. (1997): Mechanism by which insulin and muscle stimulate glucose transport. Can.J.Appl.Physiol., 22, 519-530.

  61. Cushman S., Wardzala L. (1980): Potential mechanism of insulin action on glucose transport in isolated rat adipose cell. J.Biol.Chem., 255, 4758-4762.

  62. Cybulska B. (2000): Aterogenna dyslipidemia. Medycyna po Dyplomie, marzec- -kwiecień, 39-43.

  63. Cybulska B., Szostak W. (1995): Otyłość wisceralna jako czynnik zagrożenia chorobą niedokrwienną serca. Pol.Tyg.Lek., supl. 1, 43-47.

  64. Dagogo-Jack S., Fenelli C., Paramore D., Brothers J., Landt M. (1996): Plasma leptin and insulin relationships in obese and non-obese human. Diabetes, 45, 699-701.

  65. Dallongeville J., Hecquet B., Lebel P., Edme J., Le-Fur C., Fruchard J., Auwerx J., Romon M. (1998): Short term response of circulating leptin to feeding and fasting in man: influence of circadian cycle. Int.J.Obes., 22, 728-733.

  66. Daly W., Seegers C., Timmerman S., Hackney A. (2004): Peak cortisol response to exhausting exercise: effect of blood sampling schedule. Medicina Sportiva, 1, 17-20.

  67. DeFronzo R., Gunnarsson R., Bjorkman O., Olsson M., Wahren J. (1985): Effect of insulin on peripherial and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J.Clin.Invest., 76, 149-155.

  68. DeFronzo R., Soman V., Shervin R., Hendler R., Felig P. (1978): Insulin binding to monocyte and insulin action in human obesity, starvation, and refeeding. J.Clin.Invest., 62, 204-213.

  69. Dela F., Mikines K., Sonne B., Galbo H. (1994): Effect of training on interaction between insulin and exercise in human muscle. J.Appl.Physiol., 76, 2386-2393.

  70. Despres J. (1991): Lipoprotein metabolism in visceral obesity. Int.J.Obes., 15, 45-49.

  71. Despres J. (1993): Abdominal obesity as important component of insulin-resistance syndrome. Nutrition, 9, 452-459.

  72. Despres J.P., Lamarche B. (1993): Effect of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr. Res.Rev., 6, 137.

  73. Despres J., Lamarche B. (1994): Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J.Int.Med., 236, 7-22.

  74. Despres J., Moorjani S., Lupien P., Tremblay A., Nadeau A., Bouchard C. (1990): Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis, 10, 497-511.

  75. Despres J., Lamarche B., Mauriege P., Cantin B., Dagenais G., Moorjani S., Lupien P. (1996): Hyperinsulinemia as an important risk factor for ischemic heart disease. N.Engl.J.Med., 334, 952-957.

  76. Despres J., Moorjani A., Tremblay A., Poehlman E., Lupien P., Nadeau A., Bouchard C. (1988): Heredity and changes in plasma lipids and lipoproteins after short-term exercise training in men. Arteriosclerosis, 8, 402-409.

  77. Dieguez C., Carro E., Seoane L., Garcia M., Camina J., Senaris R., Popovic V., Casanueva F. (2000): Regulation of somatotroph cell function by the adipose tissue. Int.J.Obes.Relat.Metab.Disord., 24 suppl. 2, S100-S103.

  78. Dietz W., Hartung R. (1985): Changes in height velocity of obese preadolescent during weight reduction. Am.J.Dis.Child., 139(7), 705-707.

  79. Donen A., Ramlal T., Rastogi S., Bilan P. (1990): Exercise induces recruitment of the „insulin responsive glucose transporter”. J.Biol.Chem., 265,13427-13430.

  80. Dylewicz P., Przywarska I., Szczęśniak Ł., Rychlewski T., Bieńkowska S., Długiewicz I., Wilk M. (1999): The influence of short-term endurance training on the insulin blood level, binding and degradation of 125 I-insulin by erythrocyte in patients myocardial infraction. J.Cardiol.Rehab., 19, 98-105.

  81. el-Magdadi F., Bashir N., Hasan Z., al-Hader A., Gharaibeh M. (1996): Exercise at low altitude (Jordan Valley) causes changes in serum levels of ACTH, insulin, cortisol, and lactate. Endocrine Research, 22(4), 763-767.

  82. Emilsson V., O΄Dowd J., Nolan A., Cawthorne M. (2001): Hexosamines and nutrient excess induce leptin production and leptin receptor activation in pancreatic islets and clonal beta-cells. Endocrinology, 142 (10), 4414-4419.

  83. Epstein L., Myers M., Raynor H., Saelens B. (1998): Treatment of childhood obesity. Pediatrics, 101(3), 554-570.

  84. Ernst N., Obarzanek E., Clark M., Briefel R., Brown C., Donato K. (1997): Cardiovascular health risks related to overweight. J.Am.Diet.Assoc., Suppl. 7, S47-S51.

  85. Esler M., Vaz M., Collier G., Nestel P., Jennings G., Kaye D., Seals D., Lambert G. (1998): Leptin in human plasma is derived in part from the brain, and cleared by the kidneys. Lancet, 351(9106), 879.

  86. Essig D., Alderson N., Ferguson M., Bartoli W., Durstine J. (2000): Delayed effects of exercise on the plasma leptin concentration. Metabolism, 49, 395-399.

  87. Felber J., Ferrannini E., Golay A., Meyer H., Thieubaud D., Curchod B., Maeder E., Jequier E., De Fronzo R. (1987): Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes, 36, 1341-1350.

  88. Ferguson M., Gutin B., Le N., Karp W., Litaker M., Humphries M., Okuyama T., Riggs S., Owens S. (1999): Effect of exercise training and its cessation on components of the insulin resistance syndrome in obese children. Int.J.Obes.Relat.Metab.Disord., 23, 889-895.

  89. Ferrannini E., Camastra S. (1998): Relationship between impaired glucose tolerance, non-insulin dependent diabetes mellitus and obesity. Eur.J.Clin.Invest., 28 (suppl. 2), 3-7.

  90. Feskens E., Kromhout D. (1994): Hiperinsulinemia, risk factors and coronary heart disease. The Zutphen elderly study. Arterioscler.Thromb., 14, 1641-1647.

  91. Firth R., Bell P., Rizza R. (1987): Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism, 36, 1091-1095.

  92. Fisher B., Hepburn B., Smith I., Frier B. (1990): The effect of alpha-adrenergic blocade on responses of peripherial blood cells to acute insulin – induced hypoglycaemia in humans. Eur.J.Clin.Invest., 20, 51-55.

  93. Franek E. (2001): Postępy patofizjologii otyłości i jej głównych klinicznych skojarzeń. Med.Metab., 5, 41-54.

  94. Friedman J., Halaas J. (1998): Leptin and the regulation of body weight in mammals. Nature, 395, 763-770.

  95. Friedman M., Tordoff M., Ramirea I. (1986): Integrated metabolic control of food intake. Brain.Res.Bull.,17, 855-859.

  96. Fr(hbeck G., Salvador J. (2000): Relation between leptin and the regulation of glucose metabolism. Diabetologia, 43, 3-12.

  97. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. (1987): Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism, 36, 54-59.

  98. Fukagawa N., Anderson J., Hageman G., Young V., Minaker K. (1990): High- -carbohydrate, high-fiber diets increase peripherial insulin sensitivity in healthy young and old adults. Am.J.Clin.Nutr., 52, 524-528.

  99. Galbo H. (1983): Hormonal and metabolic adaptation to exercise. Georg Thieme Verlag, Stuttgart, New York, 40-45.

  100. Galbo H. (1986): Autonomic neuroendocrine responses to exercise. Scand.J.Sports Sci., 8,1, 3-17.

  101. Gallagher M., Graham P., Holland P. (1990): The amygdala central nucleus and apetitive. Pavlovian conditioning: lesions impair one class of conditioned behavior. J.Neurosci., 10, 1906-1911.

  102. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M., Skoda R. (1996): Defective STAT signaling by the leptin receptor in diabetic mice. Proc.Natl.Acad.Sci., 93, 6231-6235.

  103. Gibney M. (1999): Nutrition, physical activity and health status in Europe: an overview. Public Health Nutrition, 2, 329-333.

  104. Gibson H., Edwards R. (1985): Muscular exercise and fatigue. Sports Med., 2, 120-132.

  105. Gippini A., Mato A., Peino R., Lage M., Dieguez C., Casanueva F. (1999): Effect of resistance exercise (body building) training on serum leptin levels in young men: implications for relationship between body mass index and serum leptin. J.Endocrinol.Invest., 22(11), 824-828.

  106. Glass A., Burman K., Dahms W., Doehm T. (1981): Endocrine function in human obesity. Metabolism, 30, 89-104.

  107. Gong D., Bi S., Pratley R., Weintraub B. (1996): Genomic structure and promoter analysis of the human obese gene. J.Biol.Chem., 271(8), 3791-3794.

  108. Górska M. (2001): Układ wydzielania wewnętrznego. [W:] Red. J. Górski, Fizjologiczne podstawy wysiłku fizycznego. PZWL, Warszawa.

  109. Grundy S. (1998): Hypertriglyceridemia, atherogenic dyslipidemia and the metabolic syndrome. Am.J.Cardiol., 81, 18B-25B.

  110. Grundy S., Denke M. (1990): Dietary influences on serum lipids and lipoproteins. J.Lipid.Res., 31, 1149-1172.

  111. Gutin B., Cucuzzo N., Islam S., Smith C., Moffatt R., Dargman D. (1995): Physical training improves body composition of black obese 7- to 11-year-old girl. Obes. Res., 3(4), 305-312.

  112. Gutin B., Owens S., Okuyama T., Riggs S., Ferguson N., Litaker M. (1999): Effect of physical training and its cessation upon percent fat and bone density of obese children. Obes.Res., 7, 208-214.

  113. Hackney A., Viru A. (1999): Twenty-four cortisol response to multiple daily exercise sessions of moderate and high intensity. Clin.Physiol., 19, 178-182.

  114. Hackney A., Premo M., McMurray R. (1995): Influence of aerobic and anaerobic exercise on the relationship between reproductive hormones in men. J.Sports Sci., 13(4), 305-310.

  115. Halaas J., Gajiwala K., Maffei M., Cohen S.L., Chait B., Rabinowitz D., Lallone R., Burley S., Friedman J. (1995): Weight-reducing effect of the plasma protein encoded by the obese gene. Science, 269, 543-546.

  116. Hamm P., Shekelle R., Stamler Y. (1989): Large fluctuations in body weight during young adulthood and twenty-five-years risk of coronary death in men. Am.J.Epidemiol., 129, 312-318.

  117. Hanaki K., Becker D., Arslanian S. (1999): Leptin before and after insulin therapy in children with new-onset type I diabetes. J.Clin.Endocrinol.Metab., 84, 1524-1526.

  118. Haque M., Minokoshi Y., Hamai M., Iwai M., Horiuchi M., Shimazu T. (1999): Role of sympathetic nervous system and insulin in enhancing glucose uptake in periferial tissues after intrahypothalamic injection of leptin in rats. Diabetes, 48, 1706-1712.

  119. Hardman A. (1999): Physical activity, obesity and blood lipids. Int.Obes.Relat.Metab. Disord., 23 (suppl. 3), S64-S71.

  120. Harris T., Gook E., Garrison R., Higgins M., Kannel W., Goldman L. (1988): Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA, 259, 1520-1524.

  121. Harris W. (1999): Nonpharmacologic treatment of hypertriglicerydemia: focus on fish oils. Clin.Cardiol., 22, Suppl. 6, II40-II43.

  122. Hartz A., Grubb B., Wild R., Van-Nort J., Kuhn E., Freedman D., Rimm A. (1990): The association of waist hip ratio and angiographically determined coronary artery disease. Int.J.Obes., 14, 657-665.

  123. Hasselwander O., McEneny J., Mcmaster D., Fogarty D., Nicholls D., Maxwell A., Young I. (1999): HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. Arteriosclerosis, 143,125-133.

  124. Hathout E., Sharkey J., Racine M., Ahn D., Mace J., Saad M. (1999): Changes in plasma leptin during the treatment of diabetic ketoacidosis. J.Clin.Endocrinol.Metab., 84, 4545-4548.

  125. Heding L., Ludvigsson J. (1980): β-cell response to exercise in diabetic and nondiabetic children. Acta Pediatr.Scand. Suppl., 283, 57-61.

  126. Heptulla R., Smitten A., Teague B., Tamborlane W., Ma Y., Caprio S. (2001): Temporal patterns of circulating leptin levels in lean and obese adolescents; relationship to insulin, growth hormone, and free fatty acids rhytmicity. J.Clin.Endocrinol.Metab., 86, 90-96.

  127. Hickey M., Israel R., Gardiner S., Considine R., McCammon M., Tyndall G., Haumard J., Marks R., Caro J. (1996): Gender differences in serum leptin levels in humans. Biochem.Mol.Med., 59(1), 1-6.

  128. Hilton L., Loucks A .(2000): Low energy availability, not exercise stress, suppresses the diurnal rhythm of leptin in healthy young women. Am.J.Physiol.Endocrinol.Metab., 278, E43-E49.

  129. Hirsch I., Marker J., Smith L., Spina R. (1991): Insulin and glucagon in prevention of hypoglycemia during exercise in humans. Am.J.Physiol., 260, E695-E704.

  130. Hoffstedt J., Shimizu M., Sjostedt S., Lönnqvist F. (1995): Determination of beta 3-adrenoreceptor mediated lypolysis in human fat cells. Obes.Res., 3(5), 447-457.

  131. Hokanson J., Austin M. (1996): Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta- -analysis of population-based prospective studies. J.Cardiovasc.Risk, 3, 213-229.

  132. Horowitz J. (2001): Regulation of lipid mobilization and oxidation during exercise in obesity. Exerc.Sport.Sci.Rev., 29, 42-46.

  133. Houmard J., Cox J., MacLean P., Barakat H. (2000): Effect of short-term exercise training on leptin and insulin action. Metabolism: Clinical Experimental, 49(7), 858-861.

  134. Houmard J., Shineberger M., Dolan P., Legget-Frazier N. (1993): Exercise training increases GLUT-4 protein concentration in previously sedentary middle-aged man. Am.J.Physiol., 264, E896-E901.

  135. Howell W., McNamara D., Tosca M., Smith B., Gaines J. (1997): Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am.J.Clin.Nutr., 65, 1747-1764.

  136. Hu F., Stampfer M., Manson J., Rimm E., Wolk A., Colditz G., Hennekens C., Willett W. (1999): Dietary intake of alfa-linolenic acid and risk of fatal ischemic heart disease among women. Am.J.Clin.Nutr., 69, 890-897.

  137. Hubert H., Feinlieb M., Mc Namara P., Castelli W. (1983): Obesity is an independent risk factor for cardiovascular diease: a 26-year follow-up of participants in the Framingham study. Circulation, 67, 968-976.

  138. Hughes V., Fiatarone M., Fielding R., Kaahn B. (1993): Exercise increase muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am.J.Physiol., 264, E855-E862.

  139. Hunter G., Weinsier L., Bamman M., Larson D. (1998): A role for high intensity exercise on energy balance and weight control. Int.J.Obes., 22, 489-493.

  140. Inoue T., Uchida T., Kamishirado H., Takayanagi K., Hayashi T., Morooka S. (2001): Clinical significance of antibody against oxidized low density lipoprotein in patients with arteriosclerotic coronary artery disease. J.Am.Coll.Cardiol., 37, 555-559.

  141. Ishizaki M., Yamada Y., Morikawa Y., Noborisaka Y., Ishida M., Miura K., Nakagawa H. (1999): The relationship between waist-to-hip ratio and occupational status and life-style factors among middle-aged male and female Japanese workers. Occup.Med., 49(3), 177-182.

  142. Iskra M., Pioruńska-Stolzman M. (2001): Przeciwutleniające właściwości lipoprotein o wysokiej gęstości i ich zmiana w reakcji ostrej fazy. Czynniki Ryzyka, 3-4, 11-18.

  143. Janik J., Curti B., Considine R., Rager H., Powers G., Alvord W., Smith J., Gause B., Kopp W. (1997): Interleukin 1-alpha incrises serum leptin concentrations in humans. J.Clin.Endocrinol.Metab., 82(9), 3084-3086.

  144. Jeppesen J., Hein H., Suadicani P., Gyntelberg F. (1998): Triglycerides concentration and ischemic heart disease. An eight-year follow up in the Copenhagen Male Study. Circulation, 97, 1029-1036.

  145. Jones J., Clemmonds D. (1995): Insulin-like growth factors and their binding proteins: biological actions. Endocrinol. Rev., 16, 3-34.

  146. Kaciuba-Uściłko H., Kruk B., Szczypaczewska M., Opaszowski B., Stupnicka E., Bicz B., Nazar K. (1992): Metabolic, body temperature and hormonal responses to repeated periods of prolonged cycloergometer exercise in man. Eur.J.Appl.Physiol., 64, 26-31.

  147. Kahn C. (1985): The molecular mechanism of insulin action. Ann.Rev.Med., 36, 429-451.

  148. Kamohara S., Burcelin R., Halaas J., Friedman J., Charron M. (1997): Acute stimulation of glucose in mice by leptin treatment. Nature, 389, 374-377.

  149. Kang H., Gutin B., Barbeau P., Owens S., Lemmon C., Allison J., Litaker M., Le N. (2002): Physical training improves insulin resistance syndrome markers in obese adolescents. Med.Sci.Sports Exerc., 34, 12, 1920-1927.

  150. Karam J. (1992): Type II diabetes and syndrome X; pathogenesis and glycaemic management. Diabetes mellitus: perspectives on therapy. Endocrinol. Metab.Clin. North Am., 21, 329-350.

  151. Karlsson C., Lindell K., Svenson E., Bergh C., Lind P., Billig H., Carlsson L., Carlsson B. (1997): Expression of functional leptin receptors in the human ovary. J.Clin.Endocrinol.Metab., 82, 4144-4148.

  152. Karpe F. (1999): Postprandial lipoprotein metabolism and arteriosclerosis. J.Intern.Med., 246, 341-355.

  153. Kasim S., Martino S., Kim P., Khilnani S., Boomer A., Depper J., Reading B., Heilbrun L. (1993): Dietary and antropometric determinants of plasma lipoproteins during a long-term, low-fat diet in healthy women. Am.J.Clin.Nutr., 57, 146-153.

  154. Kasprzak Z., Szczepanowska E., Wieliński D. (2000a): Wpływ wysiłku fizycznego na zmiany hormonalne u 14-16-letniej młodzieży z otyłością prostą. Monografie AWF, nr 331, Poznań 123-130.

  155. Kasprzak Z., Szczęśniak Ł., Rychlewski T., Gawlińska M. (2000b): Stężenie leptyny w surowicy krwi u młodzieży z otyłością prostą, poddanej terapii dietetycznej i wysiłkowej. Problemy Higieny, 68, 1, 87.

  156. Kasprzak Z., Szczęśniak Ł., Rychlewski T. (1995): Wpływ systematycznego wysiłku fizycznego oraz niskoenergetycznej diety na zachowanie się parametrów antropometrycznych i fizjologicznych u dzieci z otyłością prostą. Diabetol.Pol., 2, 42-48.

  157. Kasprzak Z., Szcześniak Ł., Rychlewski T., Gawlińska M. (2003): Plasma leptin concentration in the young with simple obesity treated with diet and physical activity. Studies in Physical Culture and Tourism, 10, 2, 111-116.

  158. Katz A., Broberg S., Sahlin K., Wahern J. (1986): Leg glucose uptake during maximal dynamic exercise in humans. Am.J.Physiol., 251, E65-E70.

  159. Katzmarzyk P., Leon A., Rankinen T., Gagnon I., Skinner J., Wilmore J., Rao D., Bouchard C. (2001): Changes in blood lipids consequent to aerobic exercise training related to changes in body fatness and aerobic fitness. Metab.Clin.Exper., 50, 841-848.

  160. Kawanaka K., Higuchi M., Ohmori H., Shimegi S. (1996): Muscle contractile activity modulates GLUT-4 protein content in the absence of insulin. Horm.Metab.Res., 28, 75-80.

  161. Kielar D., Millo B., Chełstowski K., Naruszewicz M. (1998): Stężenie leptyny w surowicy a wybrane metaboliczne czynniki ryzyka u otyłych i szczupłych pacjentów. Czynniki Ryzyka, 2/3, 36-44.

  162. King D., Staten M., Kohrt W., Dalsky G. (1990): Insulin secretory capacity in endurance-trained young men. Am.J.Physiol., 259, E155-E161.

  163. Kissebah A., Freedman D., Peiris A. (1989): Health risks of obesity. Med.Clin.North Am., 73.

  164. Klein S., Coppack S., Mohamed-Ali V., Landt M. (1996): Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes, 45(7), 984-987.

  165. Klip A., Tsakiridis T., Marette A., Ortiz P. (1994): Regulation of expression of glucose transporters by glucose: a review of studies in vivi and in cell cultures. FASEB J., 8, 43-53.

  166. Kłapcińska B., Poprzęcki S., Opyrchał C., Karpiński R., Grzesiok K. (1996): Powysiłkowe zmiany poziomu erytrocytarnego 2,3-dwufosfoglicerynianu (2,3-DPG) i adenozyno-5'-trójfosforanu (ATP) u pływaków. Wychowanie Fizyczne i Sport, 3,15-24.

  167. Knapp H. (1997): Dietary fatty acids in human thrombosis and hemostasis. Am.J.Clin.Nutr., 65 (suppl. 5), 1687s-1698s.

  168. Koehler B., Drzewiecka B. (1979): Otyłość prosta u dzieci. Część I. Wyniki leczenia w warunkach klinicznych. Przeg.Ped., 9, 295-300.

  169. Koehler B., Drzewiecka B., Ładarew-Łach I. (1981): Otyłość prosta wieku rozwojowego. Ped. Pol., 56, 573-578.

  170. Kohort W., Landt M., Birge S. (1996): Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy in older women. J.Clin.Endocrinol.Metab., 81, 3980-3985.

  171. Koistinen H., Tuominen J., Ebeling P. (1998): The effect of exercise on leptin concentration in healthy menand in type I diabetic patients. Med.Sci.Sports Exerc., 30, (6), 805-810.

  172. Kokot F., Stupnicki R. (red.) (1985): Metody radioimmunologiczne i radiokompetycyjne stosowane w klinice. PZWL, Warszawa.

  173. Kolaczyński J., Considine R., Ohannesian J., Marco Ch., Opentatowa I., Nyce M., Myint M., Caro J. (1996): Response of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes, 45, 1511-1515.

  174. Korkushko O., Frolkis M., Shatilo V., Yorschenko Yu. (1990): Hormonal and autonomic relations to exercise in elderly healthy subjects and patients with ischemic heater disease. A.Clin.Belgica, 45 (3), 164-175.

  175. Korman E. (1999): Podstawy endokrynologii wieku dziecięcego. PZWL, Warszawa.

  176. Kral J., Schaffner F., Pierson R., Wang J. (1993): Body fat topography as a independent predictor of fatty liver. Metab.Clin.Experiment., 42, 548-551.

  177. Krawczuk-Rybakowa M., Masłowiecka J., Urban M. (1987): Wpływ czasu trwania otyłości i jej nasilenia oraz obciążeń rodzinnych na frakcje cholesterolu o wysokiej gęstości – HDL i cholesterolowego współczynnika miażdżycowego – Ia u dzieci z nadmiarem masy ciała. Kard.Pol., XXX, 9, 522-527.

  178. Krawczuk-Rybakowa M., Pędziński W., Urban M., Siwiński J. (1990): Rozmieszczenie tkanki tłuszczowej u dzieci z nadmiarem masy ciała a możliwość występowania powikłań otyłości. Część III. Zależności między typem rozmieszczenia tkanki tłuszczowej a zachowaniem się wybranych parametrów gospodarki hormonalnej i tłuszczowej u dzieci. Ped.Pol., 65, 48-53.

  179. Krawczuk-Rybakowa M., Pędziński W., Urban M., Siwiński J., Malinowska I. (1989): Rozmieszczenie tkanki tłuszczowej u dzieci z nadmiarem masy ciała a możliwość występowania powikłań otyłości. Część I. Ocena wskaźnika (obwód pasa do obwodu bioder) u dzieci z otyłościa prostą. Ped.Pol., 64, 414-420.

  180. Krawczuk-Rybakowa M., Urban M., Koćmierska-Grodzka D., Pawłowska D., Pędziński W. (1984): Zachowanie się poziomu insuliny we krwi na czczo i po podaniu doustnym glukozy u dzieci z nadmiarem ciężaru ciała. Endokrynol.Pol., 35, 113-119.

  181. Kromhout D., Menotti A., Bloemberg B., Aravanis C. (1995): Dietary saturated and trans fatty acids and cholesterol and 25-years mortality from coronary heart disease: the Seven Country Study. Prev.Med., 24, 308-315.

  182. Krotkiewski M. (1990): Wysiłek fizyczny a otyłość. Wiad.Lek., 43, 449-454.

  183. Krotkiewski M., Bj(rntorp P. (1986): Muscle tissue in obesity with different distribution of adipose tissue, effects of physical training. Int.J.Obes., 10, 331-341.

  184. Kurscheid T., Lauterbach K. (1998): The cost implication of obesity for health care and society. Int.J.Obes.Relat. Metab. Disord., 22, suppl. 1, S3-S5.

  185. Landt M., Lawson G., Helgeson J., Davila-Roman V., Ladenson J., Jaffe A., Hickner R. (1997): Prolonged exercise decreased serum leptin concentrations. Metabolism, 46, 1109-1112.

  186. Lange A., Starostecka E., Graliński J. (2001): Otyłość dziecięca. Klinika Pediatryczna, vol. 9, 9, 295-297.

  187. Langfort J., Donsmark M., Ploug T., Holm C., Galbo H. (2003): Hormone-sensitive lipase in skeletal muscle: regulatory mechanisms. Acta Physiol.Scan., 178, 397-403.

  188. Larson D., Ferraro R., Robertson D., Ravussin E. (1995): Energy metabolism in weight-stable postobese individuals. Am.J.Clin.Nutr., 62, 735-739.

  189. Laughlin G., Yen S. (1997): Hypoleptinemia in women athlets: absence of a diurnal rhythm with amenorrhea. J.Clin.Endocrinol.Metab., 82, 318-321.

  190. Leahy J.L. (1990): Natural history of beta cell dysfunction in NIDDM. Diabetes Care, 13, 992-1010.

  191. Lee G.., Proenca R., Montez J., Carroll K., Darvishzadeh J., Lee J., Friedman J. (1996): Abnormal splicing of the leptin receptor in diabetic mice. Nature, 379, 632-635.

  192. Leon A., Sanchez O. (2001): Response of blood lipids to exercise training alone or combined with dietary intervention. Med.Sci.Sports Exerc., 33 (6 suppl.), S502-S515.

  193. Lepereq J., Cauzac M., Lahlou N., Timsit J., Girard J., Auwerx J., Hauguel-de Mouzon S. (1998): Over expression of placenta leptin in diabetic pregnancy: a critical role of for insulin. Diabetes, 47(5), 847-850.

  194. Levin B., Routh V. (1996): Role of the brain in energy balance and obesity. Am.J.Physiol., 271, R491-R500.

  195. Levini G., Keaney J., Vita J. (1995): Cholesterol reduction in cardiovascular disease: clinical benefis and possible mechanism. N.Engl.J.Med., 332(8), 512-521.

  196. Levitt N., Hirsch L., Rubenstein A., Polonsky K. (1993): Quantitative evolution of the effects of low-intensity exercise on insulin secretion in man. Metabolism, 42, 829-833.

  197. Lissner L., Odell P., D(Agostino R., Stokes J., Kreger B., Belanger A., Brownell K. (1991): Variability of body weight and health outcomes in the Framingham population. N.Eng.J.Med., 324, 1839-1844.

  198. Liuzzi A., Savia G., Tagliaferri M., Lucantoni R., Berselli M., Petroni M., De Medici C., Viberti G. (1999): Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int.J.Obes., 23, 1066-1073.

  199. Longeril M. de, Renaud S., Mamelle N., Salen P., Martin J., Manjaud J., Guidollet J., Touboul P., Delaye J. (1994): Mediterranean alpha-lipolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet, 343, 1454-1459.

  200. Lönnerdal B., Havel P. (2000): Serum leptin concentration in infants: effect of diet, sex, and adiposity. Am.J.Clin.Nutr., 72, 484-489.

  201. L(nnqvist F., Nordfors L., Schalling M. (1999): Leptin and its potential role in human obesity. J.Intern.Med., 245, 643-652.

  202. Lönnqvist F., Wennlund A., Arner P. (1997): Relationship between circulating leptin and peripherial fat distribution in obese subject. Int.J.Obes., 21, 255-260.

  203. Lund S., Holman G., Schmitz O., Peterson O. (1995): Contraction stimulates translocation of glucose transporter GLUT-4 in sceletal muscle through a mechanism distinct from that of insulin. Proc.Natl.Acad.Sci. USA, 92, 5817-5821.

  204. Lutosławska G. (2002): Leptyna – hormon tkanki tłuszczowej i jej rola w procesach metabolicznych. Med.Sportiva, 6, 129-143.

  205. Maffei M., Halaas J., Ravussin E. (1995): Leptin levels in human and rodent: measurement of plasma leptin and ob. RNA in obese and weight-reduced subject. Nat. Med., 1, 1155-1161.

  206. Maffeis C., Schutz Y., Schena F., Laffanello M., Pinelli L. (1993): Energy expenditure during walking and running in obese and nonobese prepubertal children. J. Pediatr., 123(2), 193-199.

  207. Majkowska L., Czekalski S. (1995): Otyłość i nadciśnienie tętnicze a zespół insulinooporności. Endokr.Pol., 46, 63-72.

  208. Mantzoros C., Liolios A., Tritos N., Kaklamani V., Daulgerakis D., Griveas I., Moses A., Flier J. (1998): Circulating insulin concentrations, smoking and alcohol intake are important independent predictors of leptin in young healthy men. Obes.Res., 6(3), 179-186.

  209. Mantzoros C., Moschos S., Avramopoulos I., Kaklamani V., Liolios A., Doulgerakis D., Griveas I., Katsilambros N., Flier J. (1997): Leptin concentration in relation to body mass index and the tumor necrosis factor-alpha system in humans. J.Clin.Endocrinol.Metab., 82(10), 3408-3413.

  210. Markiewicz K., Sysa J., Kędziora J., Cholewa M., Zakrzewska I., Górski L., Janiak A., Błaszczyk J. (1980): Adenine nucleotides and 2,3-diphosphoglycerate in the erythrocytes during physical exercise and restitution in healthy subjects. Acta.Physiol.Pol., 31, 115-120.

  211. Martin M., Jensen M. (1991): Effect of body fat distribution on regional lipolysis in obesity. J.Clin.Invest., 88, 609-613.

  212. Martin P., Darin N., Mmemlya T., Andersson B., Jern S., Björntorp P. (1992): Cortisol secretion in relation in obese premenopausal women. Metabol., vol. 41, 8, 882-886.

  213. Martinez-Gonzalez M., Martinez J., Hu F., Gibney M., Kearney J. (1999): Physical inactivity, sedentary lifestyle and obesity in the European Union. Int.J.Obes.Relat. Metab.Disord., 23(11), 1192-1201.

  214. Matsuoka H., Fors H., Boseaus I., Rosberg S., Albertsson-Wikland K., Bjarnason R. (1999): Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities. Eur.J.Endocrinol., 140, 35-42.

  215. Matsuzawa Y., Shimomura I., Nakamura T., Keno T., Kotani K., Tokunaga K. (1995): Pathophysiology and pathogenesis of visceral fat obesity. Obes.Res., 3, suppl. 2, 187S-193S.

  216. Mc Clain, Alexander T., Cooksey R., Considine R. (2000): Hexosamine stimulate leptin production in transgenic mice. Endocrinol., 141(6), 1999-2002.

  217. Meistas M.., Margolis S., Kowarski A. (1983): Hyperinsulinemia of obesity is due to decreased clearance of insulin. Am.J.Physiol., 245, E155-E159.

  218. Mensink R.., Katan M. (1992): Effects of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler.Thromb., 12, 911-919.

  219. Miller W., Lindemann A., Wallace J., Niederpruem M. (1990): Diet composition, energy intake and exercise in relation to body fat in man and women. Am.J.Clin.Nutr., 52, 426-430.

  220. Moczko J., Bręborowicz G., Tadeusiewicz R. (1998): Statystyka w badaniach medycznych. PWN, Springer, Warszawa.

  221. Mohamed-Ali V., Pinkey J., Coppack S. (1998): Adipose tissue as an endocrine and paracrine organ. Int.J.Obes., 22, 1145-1158.

  222. Mueckler M. (1990): Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes, 39, 6-11.

  223. Mueller W., Wear M., Hanis C., Emerson J., Barton S., Hewett-Emmett D., Schull W. (1991): Which measure of body fat distribution is best for epidemiologic research? Am.J.Epidemiol., 133, 858-869.

  224. Must A., Spadano J., Coakley E., Field A., Colditz A., Dietz W. (1999): The disease burden associated with overweight and obesity. JAMA, 282, 1523-1529.

  225. National Health and Nutrition Examination Survey, www.surgeongeneral.gov/topice/obesity/calltoaction/1_4.htm

  226. Nazar K., Kaciuba-Uściłko H. (1995): Aktywność ruchowa w zapobieganiu i leczeniu otyłości. Pol.Tyg.Lek., 50, supl. 1, 68-69.

  227. Nemecz M., Preininger K., Englisch R., Furnsinn C., Schneider B., Waldhausl W., Roden M. (1999): Acute effect of leptin on hepatic glycogenolisis and gluconeogenesis in perfuset rat liver. Hepatology, 29, 166-172.

  228. Niedzwiecka Z. (1988): Ocena auksologiczna otyłości prostej – aspekt teoretyczny i praktyczny. Prz. Pediatr., 18, 130-137.

  229. Niemiec A., Franek E., Kokot F. (2001): Wpływ odchudzania na oś leptyna-neuropeptyd Y u osób otyłych z cukrzycą i bez cukrzycy. Med.Metabol., 1, 18-26.

  230. Nofer J., Eckardstein A. von, Kehrel B. (2000): Poza odwrotnym transportem cholesterolu. Plejotropowe mechanizmy antyaterogennego działania HDL. Czynniki Ryzyka, 2-3, 5-17.

  231. Obmiński Z., Lerczak K., Witek K., Starczewska-Czapowska J., Olszewska-Lelonkiewicz M. (2003): Kortyzol i testosteron w osoczu krwi u łyżwiarzy figurowych przed Olimpiadą w Nagano 1998 i Salt Lake City 2002. Medycyna Sportowa, 6, 224- 229.

  232. Olive J., Miller G. (2001): Differential effects of maximal and moderate-intensity runs on plasma leptin in healthy trained subjects. Nutrition, 17(5), 365-369.

  233. Ornish D., Brown S., Scherwitz L., Billings J., Armstrong W., Ports T., McLanehan S., Kirkeeide R., Brand R., Gould K. (1990): Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet, 336, 129-133.

  234. Ortiz-Gonzales M., Abundiz-Martinez E., Munoz-Balc(zar B. (2000): Serum leptin concentration in young insulin-sensitive and insulin-resistant volunteers. Horm. Metab.Res., 32, 273-276.

  235. Ottoson M., Mårin P., Karason K., Elander A., Björntorp P. (1995a): Blocade of the glucocorticoid receptor with RU 486: effect in vitro and in vivo on humans adipose tissue lipoprotein lipase activity. Obes.Res., 3, 233-240.

  236. Ottoson M., Vikman-Adolfson K., Enerbäck S., Elander A., Björntorp P., Edén S. (1995b): Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J.Clin.Enodcrin.Metab., 80, 936-941.

  237. Owens S., Gutin B., Barbeau P., Litaker M., Allison J., Humphries M., Okuyama T., Le N. (2000): Visceral adipose tissue and markers of the insulin resistance syndrome in obese black and white teenagers. Obes.Res., 8, 287-293.

  238. Parhami F., Tintut Y., Ballard A., Fogelman A., Bemer L. (2001): Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ.Res., 88(9), 954-960.

  239. Parthasarathy S., Barnett J., Fong L. (1990): Hight-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim.Biophys.Acta, 1044, 275-283.

  240. Pasquali R., Vicennati V. (2000): Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int.Obes.Relat.Metab.Disord., 24, Suppl. 2:S47-S49.

  241. Peeke P., Oldfild E., Alexander H., Fraker D., Alexander J., Wells J., Chrousus G. (1993): Glucocorticoid receptor expression in patients with Cousing Syndrome. North American Society for the Study of Obesity, Minneapolis (Abstract).

  242. Peiris A., Sothmann M., Hennes M., Lee M., Wilson C., Gustafson A., Kissebah A. (1989): Relative contribution of obesity and body fat distribution to alterations in glucose insulin homeostasis: predictive values of selected indices in premenopausal women. Am.J.Clin.Nutr., 49, 758-760.

  243. Pelleymounter M., Cullen M., Baker M., Hecht R., Winters D., Boone T., Collins F. (1995): Effect of the obese gene product on body weight regulation in ob/ob mice. Science, 269, 540-543.

  244. Perrone L., Miraglia del Giudice E. (1998): Genetic regulation of appetite and fatness: current knowledge and future prospectives. Nutr.Research, 9, 1631-1648.

  245. Philips S., Han Xiao-Xia., Green H., Bonen A. (1996): Increments in skeletal muscle GLUT-1 and GLUT-4 after endurance training in humans. Am.J.Physiol., 270, E456-E462.

  246. Pietinen P., Vartiainen E., Seppanen R. (1996): Changes in diet in Finland from 1972 to 1992: impact of coronary heart disease risk. Prev.Med., 25, 243-250.

  247. Ploug T., Galbo H., Vinten J., Jorgensen M. (1987): Kinetics of glucose transport in rat muscle: effects of insulin concentration. Am.J.Physiol., 253, E12-E20.

  248. Ploug T., Stallknecht B., Pedersen O., Kahn B. (1990): Effect of endurance training on glucose transport capacity and glucose transporter expression in rat sceletal muscle. Am.J.Physiol., 259, E778-E786.

  249. Ploug T., Wojtaszewski J., Kristiansen S., Hespel P. (1993): Glucose transport and transporters in muscle giant vesicles: differential effects of insulin and concretions. Am.J.Physiol., 264, E270-E278.

  250. Ponikowska I. (1990): Stężenie insuliny i hormonu wzrostu we krwi podczas testu wysiłkowego u otyłych z prawidłową tolerancją węglowodanową i cukrzycą, w warunkach żywienia i głodu zupełnego. Pol.Arch.Med.Wewn., 84.

  251. Potter J., Coffman K., Reid R., Krall J., Albrink M. (1981): Effect of test meals of varying dietary fiber content on plasma insulin and glucose response. Am.J.Clin. Nutr., 3, 328-334.

  252. Pratley R., Hagberg J., Rogus E., Goldberg A. (1995): Enhanced insulin sensitivity and lower waist-to-hip ratio in master athletes. Am.J.Physiol., 268, E484-E490.

  253. Pudel V., Westenhoefer J. (1992): Dietary and behavioral principles in the treatment of obesity. International Monitor on Eating Patterns and Weight Control Medicom/Servier, 1, 2-7.

  254. Quensenberry C., Caan B., Jacobson A. (1998): Obesity, health services use, and health care costs among members of a health maintenance organization. Arch.Intern.Med., 158, 466-472.

  255. Racette S., Coppack S., Landt M., Klein S. (1997): Leptin production during moderate – intensity aerobic exercise. J.Clin.Endocrinol.Metab., 82, 2275-2277.

  256. Randle P., Hales C., Garland P.B., Newsholme E. (1963): The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus. Lancet, 1, 785.

  257. Reaven G. (1988): Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.

  258. Reaven G. (1995): The fourth musketeer – from Alexandre Dumas to Claude Bernard. Diabetologia, 38, 3-13.

  259. Reaven G., Chen Y. (1985): Role of abdominal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus. Diabetes, 34, 1055-1058.

  260. Rebuffé-Scrive M., Lundholm K., Bjorntorp P. (1985): Glucocorticoid hormone binding to human adipose tissue. Eur.J.Clin.Invest., 15, 267-271.

  261. Rebuffé-Scrive M., Andersson B., Olbe L., Bjorntorp P. (1990): Metabolism of adipose tissue in intraabdominal depots in obese men and women. Metabolism, 39, 1021-1025.

  262. Reseland J., Syversen U., Bakke I., Qvigstad G., Eide L., Hjertner O., Gordeladze J., Drevon C. (2001): Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J.Bone.Miner.Res., 16(8), 1426-1433.

  263. Rimm E., Ascherio A., Giovannucci E., Spiegelman D., Stampfer M., Willett W. (1996): Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA, 275, 447-541.

  264. Rissanen A., Heliovaara M., Knekt P., Reunanen A., Aromaa A., Maatela J. (1990): Risk of disability and mortality due to overweight in a Finnish population. B.M.J., 301, 835-837.

  265. Roberts Ch., Barnard R., Scheck S., Balon T. (1997): Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent. Am.J.Physiol., 273, E220-E225.

  266. Rohner-Jeanrenaud F. (1995): A neuroendocrine reappraisal of the dual-centre hypothesis: its implication for obesity and insulin resistance. Int.J.Obes.Relat. Metab.Disord., 19, 517-534.

  267. Rohner-Jeanrenaud F., Jeanrenaud B. (1996): Obesity, leptin and the brain. N.Eng.J.Med., 334, 292-295.

  268. Romer E. (1997): Rola leptyny w stanie sytości i głodu. Pediatr.Pol., LXXII, 9, 783-786.

  269. Romieu J., Willett W., Stamppfer M., Colditz G., Sampson L., Rosner B., Hennekens C., Speizer F. (1988): Energy intake and other determinants of relative weight. Am.J.Clin.Nutr., 47, 406-412.

  270. Romon M., Lebel P., Velly C., Marecaux N., Fruchart J., Dallongeville J. (1999): Leptin response to carbohydrate or fat meal and energy intake. Am.J.Physiol., 277, E855-E861.

  271. Rosmond R., Bj(rntorp P. (1998): The interactions between hypothalamic-pituitary- -adrenal axis activity, testosterone, insulin - like growth factor I and abdominal obesity with metabolism and blood pressure in men. Int.J.Obes.Relat.Metab.Disord., 22, 1189-1196.

  272. Rossel R., Gomis R., Casamitjana R., Segura R., Vilardell E., Rivera F. (1983): Reduced hepatic insulin extraction in obesity: relationship with plasma insulin levels. J.Clin.Endocrinol.Metab., 56, 608-611.

  273. Rowland T. (1998): The case of the elusive denominator. 10,1-5.

  274. Rössner S., Zweigbergk D., Öhlin A., Ryttig K. (1987): Weight reduction with dietary fibre supplements. Acta Med.Scand., 222, 83-88.

  275. Ruan H., Lodish H. (2003): Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine and Growth Factors Reviews, 14, 447-455.

  276. Ryan A., Pratley R., Goldberg A. (2000): Changes in plasma leptin and insulin action with resistive training in postmenopausal women. Int.J.Obes., 25, 27-32.

  277. Rybakowa M. (1993): Zaburzenia w odżywianiu. Otyłość. [W:] Zaburzenia hormonalne u dzieci i młodzieży. Red. T. Romer. Omnitech Press, Warszawa.

  278. Rychlewski T. (1989): Zachowanie się hormonu wzrostu we krwi u sportowców i osób nietrenujących pod wpływem zróżnicowanych obciążeń wysiłkowych z uwzględnieniem czynników osobniczych i poziomu wydolności fizycznej. Monografie AWF, nr 279, Poznań.

  279. Rychlewski T., Szczęśniak Ł., Kasprzak Z., Nowak A., Banaszak F., Konys L. (1996): Kompleksowa ocena reakcji organizmu otyłych chłopców na systematyczny wysiłek fizyczny skojarzony z dietą niskoenergetyczną. Pol.Arch.Med.Wewn., 46, 344-353.

  280. Rychlewski T., Szczęśniak Ł., Dylewicz P., Deskur E., Przywarska I., Kasprzak Z., Karolkiewicz J., Konys L. (1997): The influence of oral glucose intake on binding and degradation of 125I-insulin by receptors on erythrocytes as well as on insulin and C-peptide serum levels in patients after myocardial infarction and healthy individuals. J.Physiol.Pharmacol., 48, 4, 839-849.

  281. Rywik S. (2002): Epidemiologia otyłości na podstawie 17-letnich badań populacji Warszawy w średnim wieku – badanie Pol-Monica i Pol-Monica-Bis. Med.Metab., VI, 4, 16-17.

  282. Safeer R., Cornell M. (2001): Nowe spojrzenie na rolę cholesterolu frakcji HDL. Medycyna po Dyplomie, vol. 10, 8, 49-52.

  283. Saleh J., Sniderman A., Cianflone K. (1999): Regulation on plasma fatty acid metabolism. Clin.Chim.Acta, 286, 163-180.

  284. Sasaki J., Shindo M., Tanaka H., Ando M., Arakawa K. (1987): A long-term aerobic exercise program decrease the obesity index and increase high-density lipoprotein cholesterol concentration in obese children. Int.J.Obes., 11, 339-345.

  285. Scheen A., Lefébvre P. (1999): Insulin action in man. Diabetes, 22, 71-77.

  286. Schwartz M., Daliman M., Woods C. (1995): The hypothalamic response to starvation: implication of the study of wasting disorders. Am.J.Physiol., 269, R949-R957.

  287. Schwartz M., Baskin D., Bukowski T., Kuijper J., Foster D., Lasser G., Prunkard D., Porte D., Woods S., Seeley R., Weigle D. (1996): Specifity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 45, 531-535.

  288. Seidel J. (1995): Obesity in Europe: scaling an epidemic. Int.J.Obes.Relat.Metab.Disord., 19, suppl. 3, S1-S4.

  289. Senaris R., Garcia-Caballero T., Casabiel X., Gallego R., Castro R., Considine R., Dieguez C., Casanueva F. (1997): Synthesis of leptin in human placenta. Endocrinology, 138, 4501-5404.

  290. Sheu W., Lee W., Chen Y. (1999): Gender differences in relation to leptin concentration and insulin sensitivity in non-diabetic Chinese subjects. Int.J.Obes.Relat.Metab.Disord., 23, 745-759.

  291. Siemińska L., Czarnecka D., Marek B., Kos-Kudła B., Kajdaniuk D., Strzyżewski A. (2003): Znaczenie adipocytokin w rozwoju powikłań otyłości. Pol.Arch. Med.Wewn., 3(3), 321-327.

  292. Sieradzki J. ( 1993): Zespół metaboliczny (zespół X). Diag.Lab., 29, 249-254.

  293. Sinha M., Opentatowa I., Ohannesian J., Kolaczyński J., Heiman M., Hale J., Becker G., Bowsher R., Stephens T., Caro J. (1996): Evidence of free and bound leptin in human circulation. Studies in lean and obese subject and during short-term fasting. J.Clin.Invest., 98, 1277-1282.

  294. Slieker L., Sloop K., Surface P., Kriauciunas A., LaQuier F., Manetta J., Bue-Valleskey J., Stephens T. (1996): Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J.Biol.Chem., 271(10), 5301-5304.

  295. Sliwowski Z., Lorens K., Konturek S., Bielański W., Żołądź J. (2001): Leptin, gastrointestinal and stress hormones in response to exercise in fasted or fed subjects and before and after blood donation. J.Physiol.Pharmacol., 52 (1), 53-70.

  296. Smith S. (1996): The endocrinology and obesity. Endocrinol.Metab. Clin. North Am., 25, 921-942.

  297. Smith V., Kuroda M., Sompson I. (1984): Counter regulation of insulin-stimulated glucose transport by catecholamines in the isolated rat adipose tissue. J.Biol.Chem., 259, 8758-8763.

  298. Söderberg S., Olsson T., Eliasson M., Johson O., Brismar K., Carlstrom K., Ahren B. (2001): A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) obesity. Int.J.Obes., 25, 98-105.

  299. Spiegelman B., Flier J. (1996): Adipogenesis and obesity: rounding out the big picture. Cell, 87, 377-389.

  300. Stary H. (1987): Macrophages, macrofage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Arteriosclerosis, 64, 91-108.

  301. Steinberg D. (1997): Low-density lipoprotein oxidation and its pathological significance. J.Biol.Chem., 272, 20963-20966.

  302. Stephens T. (1996): Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J.Biol.Chem., 271(10), 5301-5304.

  303. Stephens T., Basinski M., Bristow T. (1995): The role of neuropeptide Y in the antyobesity action of the obese gene product. Nature, 337, 530-532.

  304. Stevens J. (1988): Does dietary fiber affect food intake and body weight? J.Am.Diet.Assoc., 88, 939-942.

  305. Stevens J., Cai J., Pamuk E., Williamson D., Thun M., Woods J. (1998): The effect of age on the association between body-mass index and mortality. N.Engl.J.Med., 338:1-7.

  306. Str(mblad G., Bj(rntorp P. (1986): Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism, 35, 323-327.

  307. Struble J., Steffens A. (1993): Neural control of insulin secretion. Horm.Metab.Res., 25, 507-512.

  308. Summers L., Samra J., Frayn K. (1999): Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? Arteriosclerosis, 147, 11-15.

  309. Swedberg J., Bj(rntorp P., Smith U., Lonnroth P. (1990): Free fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes, 39, 570-574.

  310. Szczeklik-Kumala Z., Czech A., Łaz R., Jagielinska-Kalinowska E., Bernas M., Tatoń J. (2002): Epidemiologia aterogennych zaburzeń składu lipidów krwi w zdefiniowanej populacji. Med.Metabol., VI, 1, 12-20.

  311. Szczęśniak Ł., Banaszak F., Rychlewski T., Walczak M., Kasprzak Z. (1994a): Wpływ systematycznego wysiłku fizycznego na sekrecję insuliny z komórek beta trzustki oraz zdolność wiązania i degradacji 125I-insuliny przez receptory erytrocytów u dzieci z diabetes mellitus. Endokrynol.Pol., 45, 37-45.

  312. Szczęśniak Ł., Kasprzak Z., Banaszak F. (1994b): Einflu der kalorienarmen Di(t und des aeroben K(rpertrainings auf Bindung und Degradation von 125J-Insulin durch Rezeptoren von Erthrozyten bei Kindern mit einfacher Obesit(t. (sterr.J.Sportmed., 3, 79-85.

  313. Szczęśniak Ł., Rychlewski T., Banaszak F., Kasprzak Z. (1994c): Einflu) der einmaligen Körperanstrengung von 35% VO2max auf Sekretionsfähigkeit von B-Zellen der Bauchspeicheldrüse und auf Bindungs- Degradationsfähigkeit von 125I-insulin durch Erythrozytrezeptoren bei Kindern mit Diabetes mellitus. (sterreich J. Sportmedizin, 2, 41-49.

  314. Szczęśniak L., Rychlewski T., Kasprzak Z., Banaszak F. (1997): Insulinemia and insulin resistance in obesity – the influence of systematic physical effort. Ann. of Diagn.Pediatr.Pathol., 1, (3), 220.

  315. Szostak W. (2000a): Otyłość – problem o rosnącym znaczeniu na przełomie wieków. Medycyna po Dyplomie, Wydanie specjalne, marzec, 7-11.

  316. Szostak W. (2000b): Zaburzenia metaboliczne w nadwadze i otyłości. Medycyna po Dyplomie, Wydanie specjalne, marzec, 12-16.

  317. Szostak W., Cybulska B. (1999): Narodowy Program Profilaktyki Cholesterolowej w Polsce: dokonania i wyzwania przyszłości. Med.Metab., 3, 11-18.

  318. Szostak W., Białkowska M., Cybulska B., Kłosiewicz-Latoszek L. (2000): Leczenie otyłości u ludzi dorosłych. Medycyna po Dyplomie, Wydanie specjalne, grudzień, 163-180.

  319. Tanny A. (1984): Dynamic body fat control. Muscle and Fitness, 9.

  320. Tartaglia L., Dembski M., Weng X., Deng N., Culpepper J., Devos R., Richards G., Compfield L., Clark F., Deeds J. (1995): Identification and expression cloning of a leptin receptor OB-R. Cell, 83, 1263-1271.

  321. Tatoń J. (1985) : Otyłość: patofizjologia, diagnostyka, leczenie. PZWL, Warszawa.

  322. Tatoń J. (1993a): Rzeczywiste i pozorne związki między otyłością i cukrzycą niezależną od insuliny i niektórymi innymi zaburzeniami: wnioski terapeutyczne. Pol.Tyg.Lek., 48, supl. 1, 42-47.

  323. Tatoń J. (1993b): Mechanizmy patogenetyczne cukrzycy niezależnej od insuliny. Pol.Tyg.Lek., 48, supl. 1, 5-12.

  324. Tatoń J. (1995): Zarys patogenezy otyłości. Pol.Tyg.Lek., supl. 1, 3-10.

  325. Tatoń J. (2001): Pandemia otyłości: potrzeba społecznego programu prewencji opartej na dowodach naukowych. Med.Metab., 1, 3-6.

  326. Tatoń J., Wiśniewska A., Świtka S. (1975): Badania nad udziałem zaburzeń metabolizmu komórek tkanki tłuszczowej w patogenezie diabetogennego wpływu otyłości. Pol. Arch.Med.Wewn., 53, 6-11.

  327. Tatoń J., Czech A., Bernas M., Szczeklik-Kumala Z. (1997): Patofizjologiczne podstawy komórkowej insulinooporności – niezależnego czynnika ryzyka miażdżycy. Pol.Merkuriusz Lek., 2(7), 1-4.

  328. Taylor A., Hubbard J., Anderson E. (1999): Impact of binge eating on metabolic and leptin dynamic in normal weight women. J.Clin.Endocrinol.Metab., 84, 428-434.

  329. Taylor R., Husband D., Marshal S., Turnbridge W., Alberti K. (1984): Adipocyte insulin binding and insulin sensivity in „britte” diabetes. Diabetol., 27, 441-446.

  330. Thelle D. (1985): Coronary heart disease mortality trends and related factors in Norway. Cardiology, 72, 52-58.

  331. Thong F., Hudson R., Ross R., Jenssen I., Graham T. (2000a): Plasma leptin in moderately obese men: independent effects of weight loss and aerobic exercise. Am.J.Physiol. Endocrinol.Metab., 279(2), 307-313.

  332. Thong F., McLean C., Graham T. (2000b): Plasma leptin in female athletes: relationship with body fat, reproductive, nutritional and endocrine factors. J.Appl.Physiol., 88, 2037-2044.

  333. Thorell A., Hirshman M., Nygren J., Jorfeldt L. (1999): Exercise and insulin cause GLUT-4 translocation in human skeletal muscle. Am.J.Physiol., 277, E733-E741.

  334. Thuesen L., Henriksen L., Engby B. (1986): One-year experience with low-fat, low- -cholesterol diet in patients with coronary heart disease. Am.J.Clin.Nutr., 44, 212-219.

  335. Tomaszuk A., Simpson C., Williams G. (1996): Neuropeptide Y, hypothalamus and the regulation of energy homeostasis. Horm.Res., 46, 53-58.

  336. Torjman M., Zafeiridis A., Paolone A., Wilkerson C., Considine R. (1999): Serum leptin during recovery following maximal incremental and prolonged exercise. Int.J.Sports Med., 20(7), 444-450.

  337. Treuth M., Hunter G., Figueroa-Colon R., Goran M. (1998): Effects of strength training on intra-abdominal adipose tissue in obese prepubertal girls. Med.Sci.Sports Exerc., 30(12), 1738-1743.

  338. Turpeinen A., Kuikka J., Vanninen E., Vainio P., Vanninen R., Litmanen H., Koivisto V., Bergström K., Uusitupa M. (1996): Athletic heart: a metabolic, anatomical, and functional study. Med.Sci.Sports, Exerc., 28(1), 33-40.

  339. Ukropec J., Šebökowá E., Klimeš I. (2001): Nutrient sensing, leptin and insulin action. Arch.Physiol.Biochem., 109, 1, 38-51.

  340. Van Itallie T. (1979): Obesity: adverse effect on health and longevity. Am.J.Clin.Nutr., 32, 12 Suppl., 2723-277.

  341. Vermeulen A. (1996): Decreased androgen levels and obesity in men. Ann.Med., 28, 13-15.

  342. Viru A. (1992): Plasma hormones and physical exercise. Int.J.Sports Med., 13, 201-209.

  343. Viru A., Smirnova T. (1995): Health promotion and exercise training. Sport.Med., 19, 123-136.

  344. Waaler H. (1983): Height, weight and mortality: the Norwegian experience. Acta Med.Scand., suppl. 3, 679-685.

  345. Waaler H. (1984): Height, weight and mortality. The Norwegian experience. Acta Med. Scand., suppl., 679, 1-56.

  346. Wabitsch M., Jensen P., Blum W., Christoffersen C., Englaro P., Heinze E., Rascher W., Teller W., Tornqvist H., Hauner H. (1996): Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes, 45(10), 1435-1438.

  347. Wadden T., Stunkard A. (1992): Psychosocial and economic consequences of obesity and dieting. [In:] T. Wadden, A. Stunkard: Obesity theory and therapy. Raven Press: New York, 163-178.

  348. Wang J., Liu R., Hawkins M., Barzilai N., Rossatti L. (1998): A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature (6686), 684-688.

  349. Weber L., Scrinivasan S., Berenson G. (1998): Tracking of serum lipids and lipoproteins over 12 years into young adulthood – the Bogolusa heart study (abstract). Circulation, (suppl. 2), II-48.

  350. Weinsier R., Hunter G., Heini A., Goran M., Sell S. (1998): The etiology of obesity: Relative contribution of metabolic factors, diet and physical activity. Am.J.Med., 105, 145-150.

  351. Weise M., Abad V., Considine R. (1999): Leptin secretion in Cushing’s syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone. J.Clin.Endocrinol.Metab., 84, 2075-2079.

  352. Weltman A., Pritzlaff C., Wideman L., Considine R., Fryburg D., Gutgesell M., Hartman M., Veldhuis J. (2000): Intensity and acute exercise does not affect serum leptin concentrations in young men. Med.Sci.Sports Exerc., 32(9), 1556-1561.

  353. Westerterp K. (1999): Obesity and physical activity. Int.J.Obes.Relat.Metab.Disord., 23 (suppl. 1), 59-64.

  354. Westerterp K., Meijer G., Jansen G., Saris W., Hoor F. (1991): Long-term effect of physical activity on energy balance and body composition. British J. Nutrition, 23, 123-130.

  355. WHO (1997): Obesity: preventing and managing the global epidemic. Raport of a WHO Consultation, Geneva, June.

  356. Widgren B., Herlitz H., Wikstrand J., Sjostrom L., Berglund G., Anderson O. (1992): Increased waist/hip ratio, metabolic disturbance and family history of hypertension. Hypertension, 20(4), 563-568.

  357. Wiesner G., Vaz M., Collier G., Seals D., Kaye D., Jennings G., Lmbert G., Wilkinson D., Esler M. (1999): Leptin is released from the human brain: influence of adiposity and gender. J.Clin.Endocrinol.Metab., 84(7), 2270-2274.

  358. Wilmore J. (1997): Weight gain, weight loss, and weight control: what is the role of physical activity? Nutr., 13, 820-823.

  359. Wilmore J., Despres J., Stanforth P., Mandel S., Rice T., Gagonon J., Leon A., Rao D., Skinner J., Bouchard C. (1999): Alternations in body weight and composition consequent to 20 wk of endurance training, the HERITAGE Family Study. Am.J.Clin. Nutr., 70, (3), 346-352.

  360. Wolk A., Manson J., Stampfer M., Colditz G., Hu F., Speizer., Hennekens C., Willett W. (1999): Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA, 281(21), 1998-2004.

  361. Woynarowska B. (1986): Rozmieszczenie podskórnej tkanki tłuszczowej u dzieci i młodzieży: zmiany w okresie rozwoju i skutki zdrowotne. Prz.Pediatr., 16, 125-133.

  362. Yanowski J., Yanowski S. (2000): Ostatnie postępy w badaniach podstawowych na temat otyłości. JAMA, 2, 129-132.

  363. Yki-J(rvinen H., Puhakainen I., Koivisto V. (1991): Effect of free fatty acids on glucose uptake and nonoxaditative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J.Clin.Endocrinol.Metab., 72, 1268-1277.

  364. Yu-Poth S., Zhao G., Etherton T., Naglak M., Jonnalagadda S., Kris-Etherton P. (1999): Effects of the National Cholesterol Education Programs Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am.J.Clin.Nutr., 69, 632-646.

  365. Zakrzewska K., Cusin I., Sainsbury A., Rohner-Jeanrenaud F., Jeanrenaud B. (1997): Glucocorticoids as counterregulatory hormones of leptin: toward and understanding of leptin resistance. Diabetes, 46, 717-719.

  366. Zatoński W. (1996): Rozwój sytuacji zdrowotnej w Polsce po roku 1988. Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, Warszawa.

  367. Zhang J., Sasaki S., Amano K., Kesteloot H. (1999): Fish consumption and mortality from all causes, ischemic heart disease and stroke: an ecological study. Prev.Med., 28, 520-529.

  368. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. (1994): Positional cloning of the mouse obese gene and its human homologue. Nature, 372, 425-431.

  369. Ziemlański Ś. (1996): Podstawy prawidłowego żywienia człowieka, Instytut Żywności i Żywienia, Warszawa.

  370. Zierath J., Frevert E., Ryder J., Berggren P., Kahn B. (1998): Evidence against a direct effect of leptin on glucose transport in skeletal muscle and adipocytes. Diabetes, 47, 1-4.